Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/06/23
End: 08/06/24
Due: 08/06/25
Phase: N/A
Priority: Normal
Start: 11/01/24
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 11/01/24
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 09/30/24
End: 10/01/26
Due: 10/01/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy | NCT06168084 | Yongquan Shi | user2@example.com | None | 2023-06-06 | 2024-08-06 | 2025-08-06 | - | - | 2025-07-14 |
| Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia | NCT06610266 | Yongquan Shi | user2@example.com | None | 2024-11-01 | 2026-10-31 | 2027-10-31 | - | - | 2025-07-14 |
| Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia | NCT06610760 | Yongquan Shi | user2@example.com | None | 2024-11-01 | 2026-10-31 | 2027-10-31 | - | - | 2025-07-14 |
| Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury. | NCT06617182 | Yongquan Shi | user2@example.com | None | 2024-09-30 | 2026-10-01 | 2027-10-01 | - | - | 2025-07-14 |